Q2 2021 Neogenomics Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the NeoGenomics Second Quarter 2021 Earnings Call. (Operator Instructions) It is now my pleasure to turn the floor over to your host, CEO, Mark Mallon. Sir, the floor is yours.
Thanks, Kate, and good morning, everyone. I'd like to welcome you all to NeoGenomics' 2021 Second Quarter Conference Call. Joining me for this call from our Fort Myers headquarters are Kathryn McKenzie, our Chief Financial Officer; George Cardoza, President and Chief Operating Officer of our Lab Operations; Bill Bonello, President of our Informatics Division; and Doug Brown, our Chief Strategy and Corporate Development Officer. Joining on the call via phone from California is Dr. Gina Wallar, President of our Pharma Services Division; and via phone from the United Kingdom is President of Inivata, Dr. Clive Morris. Before we begin our prepared remarks, Doug will read the standard language about forward-looking statements. Doug?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |